TY - JOUR
T1 - Adjunctive local antibiotic therapy in the treatment of peri-implantitis II: clinical and radiographic outcomes
AU - Salvi, G.E.
AU - Persson, G.R.
AU - Heitz-Mayfield, Lisa
AU - Frei, J.
AU - Lang, N.P.
PY - 2007
Y1 - 2007
N2 - Aim: To monitor over 12 months clinical and radiographic changes occurring after adjunctive local delivery of minocycline microspheres for the treatment of peri-implantitis.Material and methods: In 25 partially edentulous subjects, 31 implants diagnosed with peri-implantitis were treated. Three weeks after oral hygiene instruction, mechanical debridement and local antiseptic cleansing using 0.2% chlorhexidine gel, baseline (Day 0) parameters were recorded. Minocycline microspheres (Arestin (R)) were locally delivered to each implant site with bone loss and a probing pocket depth (PPD) >= 5 mm. Rescue therapy with Arestin (R) was allowed at Days 180 and 270 at any site exhibiting an increase in PPD >= 2 mm from the previous visit. The following clinical parameters were recorded at four sites/implant at Day 0, 10, 30, 60, 90, 180, 270 and 360: PPD, clinical attachment level (CAL), bleeding on probing (BOP) and plaque index (PII).Results: Six implants in six subjects were either rescued or exited because of persisting active peri-implantitis. Successful implants showed a statistically significant reduction in both PPD and percentage of sites with BOP between baseline and Day 360 (P <0.05). At mesial implant sites, the mean PPD reduction amounted to 1.6 mm (95% CI: 0.9-2.2 mm, P <0.001) and was accompanied by a statistically significant reduction of the BOP value (P <0.001). Binary regression analysis showed that the clinical parameters and smoking history could not discriminate between successfully treated and rescued or exited implants at any observation time point.Conclusion: Non-surgical mechanical treatment of peri-implantitis lesions with adjunctive local delivery of microencapsulated minocycline led to positive effects on clinical parameters up to 12 months.
AB - Aim: To monitor over 12 months clinical and radiographic changes occurring after adjunctive local delivery of minocycline microspheres for the treatment of peri-implantitis.Material and methods: In 25 partially edentulous subjects, 31 implants diagnosed with peri-implantitis were treated. Three weeks after oral hygiene instruction, mechanical debridement and local antiseptic cleansing using 0.2% chlorhexidine gel, baseline (Day 0) parameters were recorded. Minocycline microspheres (Arestin (R)) were locally delivered to each implant site with bone loss and a probing pocket depth (PPD) >= 5 mm. Rescue therapy with Arestin (R) was allowed at Days 180 and 270 at any site exhibiting an increase in PPD >= 2 mm from the previous visit. The following clinical parameters were recorded at four sites/implant at Day 0, 10, 30, 60, 90, 180, 270 and 360: PPD, clinical attachment level (CAL), bleeding on probing (BOP) and plaque index (PII).Results: Six implants in six subjects were either rescued or exited because of persisting active peri-implantitis. Successful implants showed a statistically significant reduction in both PPD and percentage of sites with BOP between baseline and Day 360 (P <0.05). At mesial implant sites, the mean PPD reduction amounted to 1.6 mm (95% CI: 0.9-2.2 mm, P <0.001) and was accompanied by a statistically significant reduction of the BOP value (P <0.001). Binary regression analysis showed that the clinical parameters and smoking history could not discriminate between successfully treated and rescued or exited implants at any observation time point.Conclusion: Non-surgical mechanical treatment of peri-implantitis lesions with adjunctive local delivery of microencapsulated minocycline led to positive effects on clinical parameters up to 12 months.
U2 - 10.1111/j.1600-0501.2007.01377.x
DO - 10.1111/j.1600-0501.2007.01377.x
M3 - Article
C2 - 17355354
SN - 0905-7161
VL - 18
SP - 281
EP - 285
JO - Clinical Oral Implants Research
JF - Clinical Oral Implants Research
IS - 3
ER -